Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Epilepsy | 105 | 45 | |
Seizures | 48 | 18 | |
Brain tumor | 29 | 12 | |
Adenocarcinoma (non-small cell lung cancer) | 7 | 0 | |
Cerebral arteriovascular malformation | 4 | 1 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Memory problems | 9 | |
Headaches | 6 | |
Memory loss | 5 | |
Balance problems | 4 | |
Vision problems | 3 | |
Epilepsy | 2 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 14 | |
Moderate | 27 | |
Mild | 20 | |
None | 30 |
Member evaluations
Nylrad
evaluated on Oct 14, 2008
- Perceived effectiveness for seizures: Major
- Side effects: Mild
Tonialpha
evaluated on Jun 10, 1991
- Perceived effectiveness for epilepsy: Moderate
- Side effects: Moderate
Rocko
evaluated on Jan 20, 2011
- Perceived effectiveness for epilepsy: Major
- Side effects: Mild